An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
Treatment for severe Pigmentary Maculopathy after Elmiron: A Detailed Overview
In-depth context and analysis on this topic for researchers and advocates.
Reference: Wikipedia: Medical Malpractice
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: ClinicalTrials.gov
Authoritative source for clinical, regulatory, and public-health background reading.